Sourcebio International PLC
LSE:SBI
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Net Margin
Sourcebio International PLC
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| UK |
|
Sourcebio International PLC
LSE:SBI
|
85.3m GBP |
6%
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
100.1B USD |
0%
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
60.6B EUR |
2%
|
|
| US |
|
Cigna Corp
NYSE:CI
|
69.8B USD |
2%
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
27B EUR |
5%
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.2B EUR |
4%
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.6B USD |
6%
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
20B USD |
9%
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.3B EUR |
4%
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
13.1B USD |
-44%
|
|
| US |
|
Hims & Hers Health Inc
NYSE:HIMS
|
8.8B USD |
6%
|
Sourcebio International PLC
Glance View
SourceBio International Plc engages in the provision of laboratory services in healthcare, clinical, life science research, and biopharma industries. The company is headquartered in Nottingham, Nottinghamshire. The company went IPO on 2020-10-29. The firm operates through four business segments: Infectious Disease Testing, Healthcare Diagnostics, Genomics and Stability Storage. Its Infectious Disease Testing segment offers COVID-19 antigen reverse transcription-polymerase chain reaction (RT-PCR) testing services to the national health service (NHS), private healthcare providers and private industry. Its Healthcare Diagnostics segment offers histopathology and clinical diagnostic services for the NHS and private healthcare across the United Kingdom and Ireland. Its Genomics segment offers deoxyribonucleic acid (DNA) sequencing services for pharmaceutical and biotechnology companies, academia, contract research organizations (CROs) and other research groups in the United Kingdom, Europe and North America. Its Stability Storage segment offers shelf-life testing services and equipment for pharmaceutical companies and others.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Sourcebio International PLC's most recent financial statements, the company has Net Margin of 6.5%.